Measuring Physical Activity With Implanted Cardiac Devices: A Systematic Review

Background Physical activity is predictive of cardiovascular outcomes in patients with cardiovascular implantable electronic devices, yet it is not regularly assessed in routine care. Current‐generation cardiovascular implantable electronic devices, however, continuously monitor patient activity through a built‐in accelerometer, which provides new opportunities to remotely assess patient activity, detect changes in clinical status, and incorporate these data in risk stratification models. This review critically examines the literature on device‐measured physical activity (D‐PA), with a focus on identifying methodological issues that may affect interpretation of study results. Methods and Results We conducted a systematic review of D‐PA studies published from January 1 1995 to December 30 2017, identifying 29 studies meeting inclusion criteria, 5 of which were validation reports. Few technical details about D‐PA sensors are reported, and procedures for analyzing and interpreting D‐PA data are heterogeneous. Trends in D‐PA over time and associations with clinical outcomes were reported by 22 studies, and in 7 studies, D‐PA was combined with other device parameters in risk stratification models, demonstrating modest‐to‐good sensitivity in predicting acute heart failure decompensation, hospitalization, and mortality. Conclusions Current evidence suggests that D‐PA may be useful for assessing physical activity and predicting clinical outcomes in patients with cardiovascular implantable electronic devices when combined with other device parameters. Future work must address challenges related to D‐PA data measurement, interpretation, and generalizability to support expanded clinical applications of this technology.

[1]  C. Pepine,et al.  Assessing cardiovascular risk in women: looking beyond traditional risk factors. , 2015, Trends in cardiovascular medicine.

[2]  F. R. Gilliam,et al.  Changes in Heart Rate Variability, Quality of Life, and Activity in Cardiac Resynchronization Therapy Patients: Results of the HF‐HRV Registry , 2007, Pacing and clinical electrophysiology : PACE.

[3]  Stefan Sack,et al.  A novel method--the activity log index--for monitoring physical activity of patients with heart failure. , 2002, The American journal of cardiology.

[4]  Zhaoguang Liang,et al.  Association between patient activity and long-term cardiac death in patients with implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators , 2017, European journal of preventive cardiology.

[5]  W. Abraham,et al.  Continuous Autonomic Assessment in Patients With Symptomatic Heart Failure: Prognostic Value of Heart Rate Variability Measured by an Implanted Cardiac Resynchronization Device , 2004, Circulation.

[6]  Daniel B. Kramer,et al.  Frailty, Physical Activity, and Mobility in Patients With Cardiac Implantable Electrical Devices , 2017, Journal of the American Heart Association.

[7]  A. Oláh,et al.  A comparative analysis between external accelerometer and internal accelerometer’s physical activity data from implanted resynchronization devices in patients with heart failure , 2016 .

[8]  Patterns of physical activity and survival following cardiac resynchronization therapy implantation: the ALTITUDE activity study , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  L. D. Cas,et al.  The 6 minute walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature , 2004, European journal of heart failure.

[10]  Hassan Mansour,et al.  Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices. , 2005, The American journal of cardiology.

[11]  Pacemaker Quantified Physical Activity Predicts All-Cause Mortality. , 2015, Journal of the American College of Cardiology.

[12]  M. Shoemaker,et al.  Seasonal variation of daily physical activity in individuals with heart failure , 2016, Heart international.

[13]  A. Auricchio,et al.  Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial. , 2017, Heart rhythm.

[14]  Sana M. Al-Khatib,et al.  Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[15]  Paul J. Wang,et al.  Predictive value of device-derived activity level for short-term outcomes in MADIT-CRT. , 2017, Heart rhythm.

[16]  C. Tudor-Locke,et al.  Adult self-reported and objectively monitored physical activity and sedentary behavior: NHANES 2005–2006 , 2013, International Journal of Behavioral Nutrition and Physical Activity.

[17]  Kaushik Sinha,et al.  Longitudinal Daily Activity Patterns in Individuals With Heart Failure: Derivation and Association With Prognosis and Clinical Characteristics , 2013 .

[18]  S. Sears,et al.  How active are young cardiac device patients? Objective assessment of activity in children with cardiac devices , 2017, Pacing and clinical electrophysiology : PACE.

[19]  A. Curtis,et al.  Analysis of daily activity data from implanted cardiac defibrillators: The minimum clinically important difference and relationship to mortality/life expectancy , 2012 .

[20]  C. Tudor-Locke,et al.  Pedometer-determined step count guidelines for classifying walking intensity in a young ostensibly healthy population. , 2005, Canadian journal of applied physiology = Revue canadienne de physiologie appliquee.

[21]  S. Normand,et al.  Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study , 2015, Journal of the American Heart Association.

[22]  M. Piepoli,et al.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.

[23]  S. Ebrahim,et al.  Exercise based rehabilitation for heart failure. , 2004, The Cochrane database of systematic reviews.

[24]  D. Hettrick,et al.  Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. , 2009, Journal of cardiac failure.

[25]  Sigmund A. Anderssen,et al.  Comparison of self-reported versus accelerometer-measured physical activity. , 2014, Medicine and science in sports and exercise.

[26]  Jagmeet P. Singh,et al.  Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure. , 2014, The American journal of cardiology.

[27]  A. Pressler,et al.  Validity of cardiac implantable electronic devices in assessing daily physical activity. , 2013, International journal of cardiology.

[28]  Jagmeet P. Singh,et al.  Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[29]  C. Richardson,et al.  Physical Activity and Exercise for Secondary Prevention among Patients with Cardiovascular Disease , 2013, Current Cardiovascular Risk Reports.

[30]  K. Watson,et al.  National physical activity surveillance: Users of wearable activity monitors as a potential data source , 2016, Preventive medicine reports.

[31]  E. Warman,et al.  Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds , 2014, Heart & lung : the journal of critical care.

[32]  A. Kowalk,et al.  Concurrent Validity of Daily Activity Data From Medtronic ICD/CRT Devices and the Actigraph GT3X Triaxial Accelerometer: A Pilot Study , 2017 .

[33]  R. Lampert No Further Question: Cardiac Rehabilitation Benefits Patients With Implantable-Cardioverter Defibrillators: Insurers, Are You Listening? , 2017, JACC. Clinical electrophysiology.

[34]  Yi Zhang,et al.  A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study. , 2017, JACC. Heart failure.

[35]  A. Pandey,et al.  Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator: A Meta-Analysis. , 2017, JACC. Clinical electrophysiology.

[36]  P. Mody,et al.  Most important articles on cardiovascular disease among racial and ethnic minorities. , 2012, Circulation. Cardiovascular quality and outcomes.

[37]  M. Piepoli,et al.  Exercise training in patients with chronic heart failure , 2004, BMJ : British Medical Journal.

[38]  A. Auricchio,et al.  Activity monitoring in heart failure patients with cardiac resynchronization therapy. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[39]  Richard D Riley,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement , 2015 .

[40]  William T. Abraham,et al.  Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting , 2013, European heart journal.

[41]  K. Ellenbogen,et al.  Device sensing: sensors and algorithms for pacemakers and implantable cardioverter defibrillators. , 2010, Circulation.

[42]  L. Tavazzi,et al.  Physical Activity Measured With Implanted Devices Predicts Patient Outcome in Chronic Heart Failure , 2014, Circulation. Heart failure.

[43]  S. Sears,et al.  Patient Activity Decreases and Mortality Increases After the Onset of Persistent Atrial Fibrillation in Patients With Implantable Cardioverter-Defibrillators. , 2016, JACC. Clinical electrophysiology.

[44]  S. Sears,et al.  Examination of the differential impacts of antitachycardia pacing vs. shock on patient activity in the EMPIRIC study. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.